Andrew has over 20 years of experience in manufacturing biologics & biopharmaceuticals. Prior to joining Goodwin Biotechnology, Andrew was the Senior Manager – Clinical Manufacturing and Process Development at Alkermes plc where he worked for 13 years in manufacturing (commercial and clinical) and process development. Andrew has experience developing drug candidates in the large molecule design space focusing on recombinant therapeutic proteins. Andrew began his career with Abbott Laboratories where he worked for 7 years moving up through the ranks to become the Rare Reagents Manufacturing Supervisor overseeing the mAb production suite. At Goodwin, Andrew is responsible for all manufacturing operations including GMP and non-GMP upstream, downstream and fill finish as well as associated support activities such as materials management and facilities. Andrew earned his Masters of Science degree in Engineering and Technology Management from Oklahoma State University and a Bachelor of Science degree in Biology from the University of Wisconsin.